title: Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway.
abstract: Abnormal angiogenesis is central to the pathophysiology of diverse disease processes including cancers, ischemic and atherosclerotic heart disease, and visually debilitating eye disease. Resveratrol is a naturally occurring phytoalexin that has been demonstrated to ameliorate and decelerate the aging process as well as blunt end organ damage from obesity. These effects of resveratrol are largely mediated by members of the sirtuin family of proteins. We demonstrate that resveratrol can inhibit pathological angiogenesis in vivo and in vitro by a sirtuin-independent pathway. Resveratrol inhibits the proliferation and migration of vascular endothelial cells by activating eukaryotic elongation factor-2 kinase. The active kinase in turn phosphorylates and inactivates elongation factor-2, a key mediator of ribosomal transfer and protein translation. Functional inhibition of the kinase by gene deletion in vivo or RNA as well as pharmacological inhibition in vitro is able to completely reverse the effects of resveratrol on blood vessel growth. These studies have identified a novel and critical pathway that promotes aberrant vascular proliferation and one that is amenable to modulation by pharmacological means. In addition, these results have uncovered a sirtuin-independent pathway by which resveratrol regulates angiogenesis.
authors.affiliation: Departments of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: Aslam A
authors.initials: AA
authors.lastname: Khan
authors.forename: Dru S
authors.initials: DS
authors.lastname: Dace
authors.forename: Alexey G
authors.initials: AG
authors.lastname: Ryazanov
authors.forename: Jennifer
authors.initials: J
authors.lastname: Kelly
authors.forename: Rajendra S
authors.initials: RS
authors.lastname: Apte
mesh_terms: D000263:Adenylate Kinase / Q000378:metabolism; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D054736:Elongation Factor 2 Kinase / Q000235:genetics / Q000378:metabolism*; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects* / Q000502:physiology / Q000528:radiation effects; D005123:Eye / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D007834:Lasers; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009389:Neovascularization, Pathologic; D000077185:Resveratrol; D015398:Signal Transduction / Q000187:drug effects*; D056564:Sirtuin 1 / Q000378:metabolism; D013267:Stilbenes / Q000494:pharmacology*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D013267:Stilbenes; D054736:Elongation Factor 2 Kinase; D000263:Adenylate Kinase; C470545:Sirt1 protein, mouse; D056564:Sirtuin 1; D000077185:Resveratrol
references.citation: Int J Obes Relat Metab Disord. 2002 Aug;26(8):1118-24
references.pmid: 12119578
references.citation: Nature. 2003 Sep 11;425(6954):191-6
references.pmid: 12939617
references.citation: FASEB J. 1991 Dec;5(15):3071-7
references.pmid: 1683845
references.citation: Exp Biol Med (Maywood). 2007 Feb;232(2):195-203
references.pmid: 17259326
references.citation: FEBS Lett. 1989 Jul 17;251(1-2):187-90
references.pmid: 2753158
references.citation: Nat Protoc. 2007;2(2):329-33
references.pmid: 17406593
references.citation: N Engl J Med. 2006 Oct 5;355(14):1432-44
references.pmid: 17021319
references.citation: J Mol Cell Cardiol. 2005 Nov;39(5):813-22
references.pmid: 16198371
references.citation: Stroke. 1997 Nov;28(11):2296-302
references.pmid: 9368579
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H859-66
references.pmid: 18065527
references.citation: Cancer Res. 2003 Oct 15;63(20):6894-9
references.pmid: 14583488
references.citation: Nature. 1988 Jul 14;334(6178):170-3
references.pmid: 3386756
references.citation: J Clin Neurosci. 2007 Mar;14(3):256-60
references.pmid: 17258134
references.citation: EMBO J. 2001 Aug 15;20(16):4360-9
references.pmid: 11500363
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6658-63
references.pmid: 10841563
references.citation: J Clin Invest. 2001 Oct;108(8):1167-74
references.pmid: 11602624
references.citation: FEBS Lett. 2002 Mar 6;514(1):26-9
references.pmid: 11904175
references.citation: Curr Biol. 2002 Aug 20;12(16):1419-23
references.pmid: 12194824
references.citation: Nat Rev Drug Discov. 2006 Jun;5(6):493-506
references.pmid: 16732220
references.citation: Exp Cell Res. 2007 Oct 15;313(17):3694-706
references.pmid: 17825817
references.citation: EMBO J. 2001 Aug 15;20(16):4370-9
references.pmid: 11500364
references.citation: Lab Invest. 1992 Oct;67(4):519-28
references.pmid: 1279270
references.citation: Eur J Biochem. 1993 Mar 1;212(2):511-20
references.pmid: 8444188
references.citation: Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3586-92
references.pmid: 12882811
references.citation: J Clin Invest. 2007 Nov;117(11):3421-6
references.pmid: 17975672
references.citation: Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4491-7
references.pmid: 15557459
references.citation: Nature. 2006 Nov 16;444(7117):337-42
references.pmid: 17086191
references.citation: EMBO J. 2008 Apr 9;27(7):1005-16
references.pmid: 18337751
references.citation: Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E471-8
references.pmid: 15507531
references.citation: Genes Dev. 2007 Oct 15;21(20):2644-58
references.pmid: 17938244
references.citation: J Biol Chem. 2007 Feb 9;282(6):3702-12
references.pmid: 17164244
references.citation: Cancer Lett. 2006 Jan 8;231(1):113-22
references.pmid: 16356836
references.citation: Ann Med. 2007;39(5):335-45
references.pmid: 17701476
references.citation: Mol Cell Biol. 2006 Jan;26(1):28-38
references.pmid: 16354677
references.citation: FEBS Lett. 1987 Apr 20;214(2):331-4
references.pmid: 3569528
references.citation: Biochem J. 2002 Oct 15;367(Pt 2):525-32
references.pmid: 12171600
references.citation: Biochem J. 2006 Aug 1;397(3):519-27
references.pmid: 16626303
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7217-22
references.pmid: 17438283
references.citation: Biochem J. 2001 Feb 1;353(Pt 3):621-6
references.pmid: 11171059
references.citation: Diabetes. 1996 Nov;45(11):1644-54
references.pmid: 8866574
references.citation: Biochem Biophys Res Commun. 2000 Jul 21;274(1):61-7
references.pmid: 10903896
references.citation: J Biol Chem. 2005 Nov 11;280(45):37377-82
references.pmid: 16162502
references.citation: J Biol Chem. 2002 Oct 18;277(42):39163-8
references.pmid: 12147706